Literature DB >> 17540461

A rapid DNA hybridization assay for the evaluation of antiviral compounds against Epstein-Barr virus.

Mark N Prichard1, Shannon L Daily, Geraldine M Jefferson, Amie L Perry, Earl R Kern.   

Abstract

There is a need for additional therapies for Epstein-Barr virus (EBV) infections, but the routine screening of large numbers of potential inhibitors has been difficult due to the laborious nature of traditional assays. A new rapid assay was developed to evaluate compounds for antiviral activity against this virus that is both rapid and robust. Test compounds are added to cultures of Akata cells in 96-well plates that have been induced to undergo a lytic infection. Viral DNA produced during the infection is transferred to a membrane and quantified using a non-radioactive DNA hybridization assay. This assay was validated using a set of compounds with known activity against EBV and results compared favorably to an established real-time PCR assay. Subsequent experience with this assay has confirmed that it offers improved efficiency and robustness compared to other assays used routinely to evaluate candidate compounds for antiviral activity against EBV.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17540461      PMCID： PMC1995440          DOI： 10.1016/j.jviromet.2007.04.001

Source DB:  PubMed          Journal:  J Virol Methods        ISSN： 0166-0934            Impact factor:   2.014


  13 in total

1.  Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.

Authors:  Edward Gershburg; Joseph S Pagano
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 2.  A three-dimensional model to analyze drug-drug interactions.

Authors:  M N Prichard; C Shipman
Journal:  Antiviral Res       Date:  1990 Oct-Nov       Impact factor: 5.970

3.  Inhibitory effect of cycloSaligenyl-nucleoside monophosphates (cycloSal-NMP) of acyclic nucleoside analogues on HSV-1 and EBV.

Authors:  A Meerbach; R Klöcking; C Meier; A Lomp; B Helbig; P Wutzler
Journal:  Antiviral Res       Date:  2000-01       Impact factor: 5.970

4.  Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.

Authors:  Claudia Friedrichs; Johan Neyts; Gabor Gaspar; Erik De Clercq; Peter Wutzler
Journal:  Antiviral Res       Date:  2004-06       Impact factor: 5.970

5.  Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.

Authors:  Mary C Long; Deborah J Bidanset; Stephanie L Williams; Nicole L Kushner; Earl R Kern
Journal:  Antiviral Res       Date:  2003-04       Impact factor: 5.970

6.  Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro.

Authors:  Nicole L Kushner; Stephanie L Williams; Caroll B Hartline; Emma A Harden; Deborah J Bidanset; Xinchao Chen; Jiri Zemlicka; Earl R Kern
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2003-12       Impact factor: 1.381

7.  In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.

Authors:  Stephanie L Williams; Caroll B Hartline; Nicole L Kushner; Emma A Harden; Deborah J Bidanset; John C Drach; Leroy B Townsend; Mark R Underwood; Karen K Biron; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  Activity of penciclovir against Epstein-Barr virus.

Authors:  T H Bacon; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

9.  Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.

Authors:  V L Zacny; E Gershburg; M G Davis; K K Biron; J S Pagano
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

10.  Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections.

Authors:  Mark N Prichard; Kathy A Keith; Debra C Quenelle; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.938
View more
  10 in total

1.  Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.

Authors:  Aswani Dutt Vadlapudi; Ramya Krishna Vadlapatla; Ravinder Earla; Suman Sirimulla; Jake Brain Bailey; Dhananjay Pal; Ashim K Mitra
Journal:  Pharm Res       Date:  2013-05-09       Impact factor: 4.200

2.  Synthesis and antiviral activity of certain second generation methylenecyclopropane nucleosides.

Authors:  John D Williams; Atiyya R Khan; Emma A Harden; Caroll B Hartline; Geraldine M Jefferson; Kathy A Keith; Mark N Prichard; Jiri Zemlicka; Norton P Peet; Terry L Bowlin
Journal:  Bioorg Med Chem       Date:  2012-05-01       Impact factor: 3.641

3.  Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.

Authors:  Scott H James; Caroll B Hartline; Emma A Harden; Elizabeth M Driebe; James M Schupp; David M Engelthaler; Paul S Keim; Terry L Bowlin; Earl R Kern; Mark N Prichard
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

4.  Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.

Authors:  Mark N Prichard; Debra C Quenelle; Caroll B Hartline; Emma A Harden; Geraldine Jefferson; Samuel L Frederick; Shannon L Daily; Richard J Whitley; Kamal N Tiwari; Joseph A Maddry; John A Secrist; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

5.  (Z)- and (E)-2-(1,2-dihydroxyethyl)methylenecyclopropane analogues of 2'-deoxyadenosine and 2'-deoxyguanosine. Synthesis of all stereoisomers, absolute configuration, and antiviral activity.

Authors:  Shaoman Zhou; John C Drach; Mark N Prichard; Jiri Zemlicka
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

6.  Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses.

Authors:  Mark N Prichard; John D Williams; Gloria Komazin-Meredith; Atiyya R Khan; Nathan B Price; Geraldine M Jefferson; Emma A Harden; Caroll B Hartline; Norton P Peet; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

7.  Phosphonate analogues of cyclopropavir phosphates and their E-isomers. Synthesis and antiviral activity.

Authors:  Santosh B Mhaske; Bashar Ksebati; Mark N Prichard; John C Drach; Jiri Zemlicka
Journal:  Bioorg Med Chem       Date:  2009-04-17       Impact factor: 3.641

8.  The protein kinase A pathway contributes to Hg2+-induced alterations in phosphorylation and subcellular distribution of occludin associated with increased tight junction permeability of salivary epithelial cell monolayers.

Authors:  Jitesh D Kawedia; Mengmeng Jiang; Amit Kulkarni; Holly E Waechter; Karl S Matlin; Giovanni M Pauletti; Anil G Menon
Journal:  J Pharmacol Exp Ther       Date:  2008-06-12       Impact factor: 4.030

9.  Fluorinated methylenecyclopropane analogues of nucleosides. Synthesis and antiviral activity of (Z)- and (E)-9-{[(2-fluoromethyl-2-hydroxymethyl)-cyclopropylidene]methyl}adenine and -guanine.

Authors:  Chengwei Li; Mark N Prichard; Brent E Korba; John C Drach; Jiri Zemlicka
Journal:  Bioorg Med Chem       Date:  2007-12-05       Impact factor: 3.641

10.  In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.

Authors:  Douglas G Widman; Savanna Gornisiewicz; Sharon Shacham; Sharon Tamir
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.